Novartis researchers aim to preserve kidney function – and quality of life – for patients.

New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.

Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.

The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab

Novartis researchers are working to extend the life of organ transplants

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.